Johnson & Johnson Hit With $29 Million Verdict in Case Over Talc and Asbestos

This post was originally published on this site

https://static01.nyt.com/images/2019/03/14/business/14talc-sub/14talc-sub-moth.jpg

The company’s stock dipped on Thursday after a California jury found in favor of a woman who claimed that asbestos in the company’s talc-based powders caused her cancer.